Literature DB >> 10815916

Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.

A Giatromanolaki1, M I Koukourakis, E Sivridis, K O'Byrne, G Cox, P E Thorpe, K C Gatter, A L Harris.   

Abstract

We investigated the expression of MUC1 protein and its relationship to the microvessel density and the expression of thymidine phosphorylase, vascular endothelial growth factor (VEGF), VEGF-receptor KDR, basic fibroblast growth factor (bFGF), and bFGF-receptor (FGFR-2) in non-small cell lung cancer. Although MUC1 expression was found equally in poorly and highly vascularized tumors, a significant coexpression with multiple angiogenic factors and their receptors was noted (P = 0.0002, 0.03, 0.19, 0.10, and 0.01 for thymidine phosphorylase, VEGF, KDR, bFGF, and FGFR-2, respectively). In multiple regression analysis, both angiogenesis and MUC1 expression were independent prognostic variables. The present study suggests the existence of an early genetic event leading to the activation of both migration and angiogenesis pathways in non-small cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815916

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  21 in total

1.  Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.

Authors:  Mengying Yao; Weihong Zhang; Qingxian Zhang; Lihua Xing; Aiguo Xu; Qiuhong Liu; Bing Cui
Journal:  Lung       Date:  2011-10-01       Impact factor: 2.584

2.  Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma.

Authors:  Elisa Lappi-Blanco; Johanna M Mäkinen; Siri Lehtonen; Henna Karvonen; Raija Sormunen; Kirsi Laitakari; Shirley Johnson; Riitta Mäkitaro; Risto Bloigu; Riitta Kaarteenaho
Journal:  Tumour Biol       Date:  2016-08-01

3.  MUC1 expression in pulmonary metastatic tumors: a comparison of primary lung cancer.

Authors:  Kyoichi Kaira; Takehiro Okumura; Kazuo Nakagawa; Yasuhisa Ohde; Toshiaki Takahashi; Haruyasu Murakami; Tateaki Naito; Masahiro Endo; Haruhiko Kondo; Takashi Nakajima; Nobuyuki Yamamoto
Journal:  Pathol Oncol Res       Date:  2011-10-02       Impact factor: 3.201

4.  Interleukin-8: A potent promoter of angiogenesis in gastric cancer.

Authors:  Jun Shi; Pin-Kang Wei
Journal:  Oncol Lett       Date:  2015-12-15       Impact factor: 2.967

5.  Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer.

Authors:  Dongrong Situ; Jian Wang; Yun Ma; Zhihua Zhu; Yi Hu; Hao Long; Tiehua Rong
Journal:  Med Oncol       Date:  2010-11-30       Impact factor: 3.064

6.  The role of tumor hypoxia in MUC1-positive breast carcinomas.

Authors:  Juliana Silva Zanetti; Danilo Fiqueredo Soave; João Paulo Oliveira-Costa; Giórgia Gobbi da Silveira; Leandra Náira Zambelli Ramalho; Sérgio Britto Garcia; Sérgio Zucoloto; Alfredo Ribeiro-Silva
Journal:  Virchows Arch       Date:  2011-09-03       Impact factor: 4.064

7.  Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk.

Authors:  Tiva T VanCleave; Jason H Moore; Marnita L Benford; Guy N Brock; Ted Kalbfleisch; Richard N Baumgartner; James W Lillard; Rick A Kittles; La Creis R Kidd
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

8.  RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells.

Authors:  Sadaaki Yamazoe; Hiroaki Tanaka; Tetsuji Sawada; Ryosuke Amano; Nobuya Yamada; Masaichi Ohira; Kosei Hirakawa
Journal:  J Exp Clin Cancer Res       Date:  2010-05-23

9.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

Authors:  Jacques Lapointe; Chunde Li; John P Higgins; Matt van de Rijn; Eric Bair; Kelli Montgomery; Michelle Ferrari; Lars Egevad; Walter Rayford; Ulf Bergerheim; Peter Ekman; Angelo M DeMarzo; Robert Tibshirani; David Botstein; Patrick O Brown; James D Brooks; Jonathan R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-07       Impact factor: 11.205

10.  Salivary Lactate Dehydrogenase (LDH)- A Novel Technique in Oral Cancer Detection and Diagnosis.

Authors:  Kavyashree Lokesh; Jayanthi Kannabiran; Mahesh Dathu Rao
Journal:  J Clin Diagn Res       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.